NIH Clinical and Translational Science Award (CTSA)

In October 2006, Duke received one of the first Clinical and Translational Science Awards (CTSA) from the National Institutes of Health.

The CTSA is the NIH’s largest single investment in biomedical research. The awards are given to institutions to create academic homes for translational research. The goal is to address the development and implementation of national standards and best practices for the full range of translational medicine – from discovery science through clinical research and community health.

In October 2013, the NIH renewed Duke’s CTSA, committing to $47 million over five years. In May 2018, the Duke CTSA was renewed again, for approximately $60 million over five years.

Duke uses the CTSA funds to provide resources such as biostatistical and regulatory expertise, funding to move ideas from the laboratory through early-phase clinical trials, project management support, data sharing and informatics tools, and education for current and future translational medicine researchers.

Three principal investigators lead Duke’s CTSA program:

  • L. Ebony Boulware, MD, MPH, chief of the Division of General Internal Medicine, vice dean for translational science, and associate vice chancellor for translational research in the School of Medicine
  • Jennifer Li, MD, MHS, chief of the Division of Pediatric Cardiology
  • James McNamara, MD, director of the Center for Translational Neuroscience

As a CTSA recipient, Duke is part of a consortium that includes more than sixty institutions across the country. The National Center for Advancing Translational Sciences (NCATS) oversees the work of this consortium.

Learn more about the CTSA teams and projects at Duke. 

We are transforming medicine. Will you join us? 

By law, publications supported by the Duke CTSA must cite the CTSA number, UL1TR002553, and be submitted to PubMed Central. For instructions, review the NIH Public Access Policy.

 


Citing the Duke CTSA

On publications:

“Research reported in this publication was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002553. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

On other support documents:

UL1TR002553 Boulware (PI) 05/02/18–4/30/23
Duke CTSA

The Duke CTSA catalyzes the translation of scientific discoveries into health benefits for communities through collaborative research. It provides key infrastructure, resources, and learning opportunities for translational researchers at Duke and its partners. The grant supports research through pilot funding, training and career development, and Cores with expertise in research design, regulatory, biomedical informatics, data sciences, recruitment, participant interactions, community engagement, special populations, team science,  and workforce development.

By law, publications supported by the Duke CTSA must cite the CTSA grant number, UL1TR002553, and be submitted to PubMed Central. For instructions, review the NIH Public Access Policy.

Key Contacts